ELDN short interest
Eledon Pharmaceuticals Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 7,847,702 |
|---|---|
| Change vs prior report | -411,566 (-5.0%) |
| Change over six months | +9.1% |
| Days to cover | 8.83 (sector: 3.78) |
| Average daily volume | 888,937 |
| Rank in Healthcare | #158 of 922 by days to cover |
ELDN short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 7,847,702 | -5.0% | 8.83 | 888,937 |
| 2026-09-15 | 8,259,268 | +6.6% | 8.99 | 919,103 |
| 2026-08-31 | 7,746,695 | +23.2% | 8.08 | 958,381 |
| 2026-08-14 | 6,289,078 | +1.2% | 6.87 | 915,083 |
| 2026-07-31 | 6,213,318 | +12.5% | 6.49 | 957,400 |
| 2026-07-15 | 5,522,678 | -29.5% | 3.87 | 1,426,048 |
| 2026-06-30 | 7,832,853 | +4.4% | 3.22 | 2,432,170 |
| 2026-06-15 | 7,501,607 | +3.0% | 7.46 | 1,005,477 |
| 2026-05-29 | 7,283,375 | +7.4% | 7.91 | 920,216 |
| 2026-05-15 | 6,781,022 | -10.2% | 5.36 | 1,265,745 |
| 2026-04-30 | 7,553,023 | -3.3% | 3.62 | 2,085,290 |
| 2026-04-15 | 7,812,771 | +8.6% | 6.21 | 1,257,972 |
| 2026-03-31 | 7,193,953 | -14.5% | 4.21 | 1,709,577 |
| 2026-03-13 | 8,417,915 | +30.3% | 6.51 | 1,292,590 |
| 2026-02-27 | 6,458,931 | +1.1% | 7.68 | 840,495 |
| 2026-02-13 | 6,389,298 | -0.1% | 13.18 | 484,688 |
| 2026-01-30 | 6,392,263 | +1.1% | 10.47 | 610,359 |
| 2026-01-15 | 6,323,235 | +4.7% | 7.31 | 865,188 |
| 2025-12-31 | 6,040,051 | +6.8% | 6.70 | 901,803 |
| 2025-12-15 | 5,656,993 | +20.7% | 5.75 | 984,674 |
| 2025-11-28 | 4,685,209 | -6.3% | 1.66 | 2,819,524 |
| 2025-11-14 | 5,001,990 | +16.8% | 1.00 | 5,400,151 |
| 2025-10-31 | 4,281,446 | +21.8% | 2.02 | 2,121,427 |
| 2025-10-15 | 3,515,385 | -47.5% | 3.46 | 1,015,113 |
| 2025-09-30 | 6,691,429 | +23.2% | 5.61 | 1,192,705 |
import finzdata as yf
yf.Ticker("ELDN").short_interest # every report since 2017
yf.Client().short_interest(["ELDN"], start="2018-01-01")Healthcare short interest · ELDN price history · Who owns ELDN · All short interest